Inozyme Pharma, Inc. (NASDAQ:INZY – Get Free Report) CEO Douglas A. Treco sold 7,523 shares of the firm’s stock in a transaction on Tuesday, April 2nd. The shares were sold at an average price of $6.94, for a total value of $52,209.62. Following the completion of the sale, the chief executive officer now owns 20,665 […]
Inozyme Pharma, Inc. (NASDAQ:INZY – Get Free Report) CEO Douglas A. Treco sold 7,523 shares of the business’s stock in a transaction that occurred on Tuesday, April 2nd. The shares were sold at an average price of $6.94, for a total value of $52,209.62. Following the completion of the sale, the chief executive officer now […]
State Of The Orphan Space lifescienceleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lifescienceleader.com Daily Mail and Mail on Sunday newspapers.